CD47 and bladder transitional cell carcinoma: [45] CD274, IDO1, CTLA4, ICOS, TIGIT, IL10, TNFRSF9, HAVCR2 exhibited significant co -expression with CD47 in BLCA, BRCA, CESC, COAD, READ, CRC, ESCA, ESCC, GBM, HNSC, LUSC, OSCC, OV, SKCM, STAD, TGCT, THCA, UCS; NFKB1, GRB2, NFATC3, YY1, NFATC2IP, PRDM1, and FOXO1 in other cancers.